MoneyWorks4Me

Bharat Immunological And Biological Corporation informs about unaudited financial results

30 Oct 2021 Evaluate

In pursuance of the LODR with Stock Exchange, Bharat Immunological And Biological Corporation has informed that it enclosed the Unaudited quarterly financial results for the quarter and half year ended September 2021 approved by the Board of the Company in its Meeting on 29.10.2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..